Ohad Etzion

2.8k total citations
69 papers, 854 citations indexed

About

Ohad Etzion is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Ohad Etzion has authored 69 papers receiving a total of 854 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Epidemiology, 37 papers in Hepatology and 14 papers in Surgery. Recurrent topics in Ohad Etzion's work include Liver Disease Diagnosis and Treatment (35 papers), Hepatitis B Virus Studies (23 papers) and Hepatitis C virus research (23 papers). Ohad Etzion is often cited by papers focused on Liver Disease Diagnosis and Treatment (35 papers), Hepatitis B Virus Studies (23 papers) and Hepatitis C virus research (23 papers). Ohad Etzion collaborates with scholars based in Israel, United States and Japan. Ohad Etzion's co-authors include Victor Novack, Avi Porath, Alan Jotkowitz, Varun Takyar, Christopher Koh, Theo Heller, Yaron Rotman, Naim Abu‐Freha, David Yardeni and Pallavi Surana and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Ohad Etzion

59 papers receiving 833 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ohad Etzion Israel	16	477	342	247	161	65	69	854
Carmen Fierbințeanu‐Braticevici Romania	14	735 1.5×	447 1.3×	273 1.1×	51 0.3×	107 1.6×	57	1.1k
Peter Ghali Canada	20	754 1.6×	606 1.8×	443 1.8×	56 0.3×	102 1.6×	53	1.3k
Ahmed Abdel‐Razik Egypt	15	492 1.0×	380 1.1×	227 0.9×	30 0.2×	78 1.2×	43	715
Hugo Perazzo Brazil	16	844 1.8×	586 1.7×	112 0.5×	66 0.4×	163 2.5×	60	1.1k
Edward Lebovics United States	16	464 1.0×	431 1.3×	238 1.0×	42 0.3×	17 0.3×	68	837
B Maharaj South Africa	11	586 1.2×	436 1.3×	163 0.7×	95 0.6×	33 0.5×	44	966
Atilla Ökten Türkiye	18	530 1.1×	525 1.5×	325 1.3×	24 0.1×	74 1.1×	48	922
Ehud Melzer Israel	18	505 1.1×	206 0.6×	492 2.0×	93 0.6×	98 1.5×	71	1.2k
Shou‐Wu Lee Taiwan	17	217 0.5×	186 0.5×	347 1.4×	34 0.2×	47 0.7×	75	790
Sophia Horster Germany	12	223 0.5×	114 0.3×	96 0.4×	48 0.3×	38 0.6×	37	623

Countries citing papers authored by Ohad Etzion

Since Specialization

Citations

This map shows the geographic impact of Ohad Etzion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ohad Etzion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ohad Etzion more than expected).

Fields of papers citing papers by Ohad Etzion

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ohad Etzion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ohad Etzion. The network helps show where Ohad Etzion may publish in the future.

Co-authorship network of co-authors of Ohad Etzion

This figure shows the co-authorship network connecting the top 25 collaborators of Ohad Etzion. A scholar is included among the top collaborators of Ohad Etzion based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ohad Etzion. Ohad Etzion is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yardeni, David, et al.. (2025). Impact of Universal Screening for HDV in HBV‐ Infected Patients on Chronic HDV Detection Rate in Israel. Journal of Viral Hepatitis. 32(7). e70046–e70046.

Uchida, Takuro, Masataka Tsuge, Nobuhiko Hiraga, et al.. (2024). Interferon alpha induces a stronger antiviral effect than interferon lambda in HBV/HDV infected humanized mice. Virus Research. 349. 199451–199451.

Abu‐Freha, Naim, et al.. (2024). Nonalcoholic Fatty Liver Disease and Ethnicity: Lessons Learned from the Arab Population in Israel. Journal of Immigrant and Minority Health. 26(5). 859–865.

Haim, Yulia, Nikhil S. Bhandarkar, Aryeh Shaleṿ, et al.. (2024). Circulating isomiRs May Be Superior Biomarkers Compared to Their Corresponding miRNAs: A Pilot Biomarker Study of Using isomiR-Ome to Detect Coronary Calcium-Based Cardiovascular Risk in Patients with NAFLD. International Journal of Molecular Sciences. 25(2). 890–890. 2 indexed citations

Townsend, Elizabeth C., Lisa Scheuing, Shakuntala Rampertaap, et al.. (2024). Taurine-conjugated bile acids and their link to hepatic S1PR2 play a significant role in hepatitis C–related liver disease. Hepatology Communications. 8(7). 7 indexed citations

Kushner, Tatyana, et al.. (2023). Modeling-Based Response-Guided Hepatitis C Treatment During Pregnancy and Postpartum. Open Forum Infectious Diseases. 10(2). ofad027–ofad027.

Yardeni, David, et al.. (2023). MELD-Na score may underestimate disease severity and risk of death in patients with metabolic dysfunction-associated steatotic liver disease (MASLD). Scientific Reports. 13(1). 22113–22113. 4 indexed citations

Abu‐Freha, Naim, et al.. (2022). THE IMPACT OF THE COVID-19 PANDEMIC ON COLORECTAL AND GASTRIC CANCER DIAGNOSIS, DISEASE STAGE AND MORTALITY. Endoscopy. 54(S 01). S115–S116.

Yang, Alexander H., Ma Ai Thanda Han, Niharika Samala, et al.. (2022). Characterization of Hepatic Dysfunction in Subjects Diagnosed With Chronic GVHD by NIH Consensus Criteria. Transplantation and Cellular Therapy. 28(11). 747.e1–747.e10. 2 indexed citations

10.

Abu‐Freha, Naim, Muhammad Abu Tailakh, Keren Rouvinov, et al.. (2022). The impact of the COVID-19 pandemic on colorectal and gastric cancer diagnosis, disease stage and mortality. Frontiers in Medicine. 9. 954878–954878. 10 indexed citations

11.

Churkin, Alexander, Ashish Goyal, Scott J. Cotler, et al.. (2021). Machine learning for mathematical models of HCV kinetics during antiviral therapy. Mathematical Biosciences. 343. 108756–108756. 7 indexed citations

12.

Tailakh, Muhammad Abu, et al.. (2021). Liver Cirrhosis, Etiology and Clinical Characteristics Disparities Among Minority Population. Journal of Immigrant and Minority Health. 24(5). 1122–1128. 5 indexed citations

13.

Wieland, Amanda, Ohad Etzion, Elliot Levy, et al.. (2021). HepQuant SHUNT Detects Portal Hypertension in Early Stages of Clinically Compensated Chronic Liver Disease. Clinical Gastroenterology and Hepatology. 20(4). e890–e894. 16 indexed citations

14.

Koh, Christopher, Ma Ai Thanda Han, Peter J. Walter, et al.. (2019). A randomized, proof-of-concept clinical trial on repurposing chlorcyclizine for the treatment of chronic hepatitis C. Antiviral Research. 163. 149–155. 7 indexed citations

15.

Yakov, Gil Ben, Hawwa Alao, Pallavi Surana, et al.. (2019). Vibration Controlled Transient Elastography (Fibroscan®) in sickle cell liver disease ‐ could we strike while the liver is hard?. British Journal of Haematology. 187(1). 117–123. 7 indexed citations

16.

Han, Ma Ai Thanda, Osama Altayar, Shadi Hamdeh, et al.. (2018). Rates of and Factors Associated With Placebo Response in Trials of Pharmacotherapies for Nonalcoholic Steatohepatitis: Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology. 17(4). 616–629.e26. 86 indexed citations

17.

Abu‐Freha, Naim, et al.. (2018). ASCA and ANCA among Bedouin Arabs with inflammatory bowel disease, the frequency and phenotype correlation. BMC Gastroenterology. 18(1). 153–153. 9 indexed citations

18.

Munteanu, Daniela, Ohad Etzion, Gil Ben Yakov, et al.. (2017). Efficacy and safety of sequential versus quadruple therapy as second-line treatment for helicobacter pylori infection—A randomized controlled trial. PLoS ONE. 12(9). e0183302–e0183302. 18 indexed citations

19.

Delgado, Jorge, Yael Baumfeld, Victor Novack, et al.. (2011). Efficacy of combined pegylated interferon and ribavirin therapy in Jewish patients of Israel suffering from chronic hepatitis C. Hepatology International. 5(4). 985–990. 2 indexed citations

20.

Etzion, Ohad, et al.. (2005). Fiber-optic biosensor to assess circulating phagocyte activity by chemiluminescence. Biosensors and Bioelectronics. 21(7). 1210–1218. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact